Phase II trial of chemotherapy with temozolomide in combination with topotecan for central nervous system (CNS) metastases of solid tumors.

Trial Profile

Phase II trial of chemotherapy with temozolomide in combination with topotecan for central nervous system (CNS) metastases of solid tumors.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Temozolomide (Primary) ; Topotecan (Primary)
  • Indications Cancer metastases; Solid tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Dec 2012 New source identified and integrated: ClinicalTrials.gov record.
    • 07 Jun 2010 Trial design details have been presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO 2010).
    • 04 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top